SCNX · Scienture Holdings Inc
United States · RS rating 10 · As of 2026-11-03
| Price | 3.45 USD |
|---|---|
| 1-day change | +6.8% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 41 / 5 / 8 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 4 / 40 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | +12.5% |
| Sales growth Q/Q | -128.6% |
| Distance from 52-week high | +83.1% |
| Market cap (USD) | $17.0M |